Beth Moughan

Pediatrics

2450 W Hunting Park Ave # 3/208N
Philadelphia, PA 19129

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Erratum to "Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose" [Vaccine 43 (2025) 126469].

Erratum to "Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose" [Vaccine 43 (2025) 126469].

Journal: Vaccine

Published: July 09, 2026

A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB-fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency.

A Phase 4 Trial to Describe the Immunogenicity, Safety, and Tolerability of MenB-fHbp in Participants > 10 Years of Age With Asplenia or Complement Deficiency.

Journal: American journal of hematology

Published: August 29, 2025

Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trial.

Immunogenicity and safety of a pentavalent meningococcal MenABCWY vaccine in healthy adolescents and young adults: a phase 3, multicountry, randomised, observer-blinded, active-controlled non-inferiority trial.

Journal: The Lancet. Child & adolescent health

Published: August 27, 2025

Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose.

Randomized trial showing persistence of hSBA titers elicited by a pentavalent meningococcal MenABCWY vaccine for up to 4 years following a primary series and safety and immunogenicity of a booster dose.

Journal: Vaccine

Published: April 30, 2024

Effect of Education and Cardboard Bassinet Distribution on Newborn Bed-Sharing.

Effect of Education and Cardboard Bassinet Distribution on Newborn Bed-Sharing.

Journal: Global pediatric health

Published: August 16, 2018

Kids Safe and Smokefree (KiSS) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial.

Kids Safe and Smokefree (KiSS) Multilevel Intervention to Reduce Child Tobacco Smoke Exposure: Long-Term Results of a Randomized Controlled Trial.

Journal: International journal of environmental research and public health

Published: April 29, 2018

An Office-Initiated Multilevel Intervention for Tobacco Smoke Exposure: A Randomized Trial.

An Office-Initiated Multilevel Intervention for Tobacco Smoke Exposure: A Randomized Trial.

Journal: Pediatrics

Published: September 06, 2017

Identifying Persistent Asthma in Children: A Comparison of Healthcare Effectiveness Data and Information Set Criteria and National Heart, Lung, and Blood Institute Guidelines.

Identifying Persistent Asthma in Children: A Comparison of Healthcare Effectiveness Data and Information Set Criteria and National Heart, Lung, and Blood Institute Guidelines.

Journal: Journal for healthcare quality : official publication of the National Association for Healthcare Quality

Published: August 25, 2017

Factors Associated With Infant Bed-Sharing.

Factors Associated With Infant Bed-Sharing.

Journal: Global pediatric health

Published: December 16, 2016

Factors that Affect Nonurgent Emergency Department Visits in a Publicly Insured Pediatric Population: An Observational Study.

Factors that Affect Nonurgent Emergency Department Visits in a Publicly Insured Pediatric Population: An Observational Study.

Journal: Journal for healthcare quality : official publication of the National Association for Healthcare Quality

Published: June 27, 2015

Kids Safe and Smokefree (KiSS): a randomized controlled trial of a multilevel intervention to reduce secondhand tobacco smoke exposure in children.

Kids Safe and Smokefree (KiSS): a randomized controlled trial of a multilevel intervention to reduce secondhand tobacco smoke exposure in children.

Journal: BMC public health

Published: July 19, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026